Patent · US Active

Spray foam corticosteroid product

US9265727B1 · kind B1 · utility

33Cited by
5References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 14, 2015
Grant dateFeb 23, 2016
Priority date
Expiry dateJan 14, 2035

Classification

  • Technology area (CPC B)Performing Operations; Transporting
  • CPC primaryB65D83/20
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A foamable pharmaceutical composition and a method of treating corticosteroid-responsive dermatoses of the skin are disclosed. The foamable pharmaceutical composition comprises a corticosteroid compound as an active ingredient; a quick-break foaming agent including an aliphatic alcohol, water, a fatty alcohol and a surface active agent; a buffering agent; and a propellant. The foamable composition is disposed within a pressurizable container that comprises an aerosol valve assembly including a dip tube communicating with a valve orifice through which the foamable composition is dispensed and an actuator to start and stop dispensation. The valve assembly dispenses a conically-shaped spray at a rate of about 2 to about 0.3 g/sec and provides a foam having a density of about 0.12 to about 0.25 when sprayed at a distance of about 5 to about 10 cm from the valve orifice onto a glass surface that is at ambient room temperature.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.